Genomic Valley

Genomic_Valley03 May 2024

Miscellaneous

₹

-0.49 (-1.58%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Genomic Valley

Genomic Valley

Miscellaneous

Genomic_Valley03 May 2024

₹

-0.49 (-1.58%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
03-May-2024	BC	Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 inter alia to consider and approve The Boad meeting of the company will	09-May-2024
03-Feb-2024	BC	Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve the Un-Audited Financial Results for	14-Feb-2024
14-Feb-2024	BC	Change in Directorate	14-Feb-2024
14-Dec-2023	BC	Resignation of Non-Executive Independent Director of the Company	14-Dec-2023
02-Nov-2023	BC	Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Un-Audited Financial Results for	14-Nov-2023

No Rights has been declared by Genomic_Valley

Book Closure

Record Date	Split Date	Purpose
09-May-2024	-	Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 inter alia to consider and approve The Boad meeting of the company will
14-Feb-2024	01 Jan'1900	Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve the Un-Audited Financial Results for
14-Feb-2024	-	Change in Directorate
14-Dec-2023	-	Resignation of Non-Executive Independent Director of the Company
14-Nov-2023	01 Jan'1900	Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Un-Audited Financial Results for

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Genomic Valley Biotech Ltd ₹30.50(-0.49/-1.58%)	30.50	-0.49	9.32	47.34	9.10	2.60
MPIL Corporation Ltd ₹805.95(-42.40/-5.00%)	805.95	-42.40	45.94	207.03	69.60	2.98
Jaykay Enterprises Ltd ₹129.45(-4.00/-3.00%)	129.45	-4.00	756.73	155.28	128.17	5.28
Modi Rubber Ltd ₹100.00(+2.35/2.41%)	100.00	+2.35	250.40	65.18	11.35	0.66
FGP Ltd ₹7.40(+0.34/4.82%)	7.40	+0.34	8.81	24.37	0.00	2.76
TCI Industries Ltd ₹1,408.50(+56.15/4.15%)	1,408.50	+56.15	126.77	10.91	0.00	13.73

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.04	0.07	0.06	1.00	0.67	0.02
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.04	0.07	0.06	1.00	0.67	0.02
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.04	0.01	0.10
Total Income	0.04	0.07	0.06	1.04	0.68	0.12
Total Expenditure	0.02	0.04	0.03	0.06	1.53	0.05
PBIDT	0.02	0.02	0.03	0.97	-0.85	0.07
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.02	0.02	0.03	0.97	-0.85	0.07
Depreciation	0.00	0.00	0.00	-0.01	0.00	0.01
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.02	0.02	0.03	0.98	-0.85	0.06
Extra-ordinary Items	0.00	0.00	0.00	0.03	-0.90	0.09
Adjusted Profit After Extra-ordinary item	0.02	0.02	0.03	0.95	0.05	-0.03

EPS (Unit Curr.)	0.07	0.08	0.09	3.21	-2.79	0.20
EPS (Adj) (Unit Curr.)	0.07	0.08	0.00	0.00	-2.79	0.00
Calculated EPS (Unit Curr.)	0.07	0.08	0.09	3.21	-2.79	0.20
Calculated EPS (Adj) (Unit Curr.)	0.07	0.08	0.00	0.00	-2.79	0.00
Calculated EPS (Ann.) (Unit Curr.)	0.28	0.30	0.35	12.83	-11.18	0.80
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.28	0.30	0.00	0.00	-11.18	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.05	3.05	3.05	3.05	3.05	3.05
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	50.00	28.57	50.00	97.00	-126.87	350.00
PBDTM(%)	50.00	28.57	50.00	97.00	-126.87	350.00
PATM(%)	50.00	28.57	50.00	98.00	-126.87	300.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	3.05	3.05	3.05	3.05	3.05	3.05
Reserves Total	0.47	-0.18	1.43	1.99	1.71	1.47
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	3.52	2.87	4.48	5.04	4.76	4.52
Secured Loans	0.00	0.00	1.55	1.48	1.48	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.75
Total Debt	0.00	0.00	1.55	1.48	1.48	0.75
Total Liabilities	3.52	2.87	6.03	6.52	6.24	5.27
APPLICATION OF FUNDS :
Gross Block	0.48	2.57	6.60	5.02	4.70	4.32
Less : Accumulated Depreciation	0.48	0.82	0.74	0.55	0.39	0.20
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	1.75	5.86	4.47	4.31	4.12
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.49	0.49	0.49	0.38
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.12	0.12	0.03
Sundry Debtors	2.22	0.00	0.06	0.10	0.06	0.02
Cash and Bank	0.04	0.00	0.01	0.04	0.08	0.01
Loans and Advances	0.32	1.14	0.09	0.14	0.05	0.02
Total Current Assets	2.58	1.14	0.16	0.40	0.30	0.09
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.89	0.20	0.86	0.76	0.04	1.36
Provisions	0.01	0.01	0.01	0.01	0.03	0.03
Total Current Liabilities	0.89	0.21	0.87	0.77	0.08	1.39
Net Current Assets	1.68	0.92	-0.71	-0.37	0.22	-1.30
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.01	0.07	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.01	0.01
Net Deferred Tax	0.00	0.00	0.01	0.07	-0.01	-0.01
Total Assets	1.68	2.67	5.65	4.66	5.01	3.19
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.00	0.01	0.04	0.08	0.01
Net Cash from Operating Activities	-0.78	-2.13	1.48	0.44	-1.04
Net Cash Used In Investing Activities	1.52	3.67	-1.58	-0.47	0.37
Net Cash Used In Financing Activities	-0.70	-1.55	0.07	0.00	0.73
Net Inc./Dec In Cash And Cash Equivalents	0.04	-0.01	-0.03	-0.04	0.06
Cash And Cash Equivalents At End Of The Year	0.04	0.00	0.01	0.04	0.08

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

64.20%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

35.80%

**Promoter pledged shareholding 64.20%

About Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd is in the Miscellaneous sector, having a market capitalization of Rs. 9.32 crores. It has reported a sales of Rs. 0.04 crores and a net profit of Rs. 0.02 crores for the quarter ended December 2018. The company management includes Yogesh Agrawal, Yogesh Agrawal,Parul Agrawal,Kapoor Chand Garg,RAHUL KUMAR PATHAK,Gupta Pradeep,Jyoti Bansal,praveen Kumar Mishra (Genomic Valley Biotech Ltd) among others.

Chairman

Yogesh Agrawal

Registered office

4 KM Stone Berry Chhara Road,Tehsil Bahadurgarh,jhajjar,Haryana,124507

FAX :

Background

Incorporation Year1994

Face Value₹10

Market Lot1

How to buy Genomic Valley shares on nse?

To buy Genomic Valley shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Genomic Valley share price today?

The Genomic Valley shares price on nse is Rs.30.5 today.

What is the market cap of Genomic Valley shares on BSE ?

The company has a market capitalization of Rs.9.32Cr

What is the PE & PB ratio of Genomic Valley shares ?

PE is 9.1 and PB is 2.6

What is the 52 Week High and Low of Genomic Valley shares?

Genomic Valley stock price high: Rs.50.14 Genomic Valley stock price low: Rs.20.65